Nephrology Dialysis Transplantation

Familial steroid-resistant nephrotic syndromes: recent advances
pp. 1897-1900(4)
Authors: Fuchshuber A.; Mehls O.

Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?
pp. 1900-1902(3)
Authors: Ruggenenti P.; Remuzzi G.

New insights into the paradoxical effect of thiazides in diabetes insipidus therapy
pp. 1903-1905(3)
Author: Magaldi A.J.

An assessment of the methods available to determine nutritional equilibrium in patients with chronic renal failure
pp. 1906-1908(3)
Authors: Roberts R.G.; Louden J.D.; Goodship T.H.J.

Degranulation of polymorphonuclear leukocytes by dialysis membranes—the mystery clears up?
pp. 1909-1910(2)
Authors: Schmaldienst S.; Hörl W.H.

Depression in chronic dialysis patients: assessment and treatment
pp. 1911-1913(3)
Authors: Finkelstein F.O.; Finkelstein S.H.

Lymphoproliferative disease post-renal transplantation
pp. 1913-1916(4)
Author: Newstead C.G.

Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A
pp. 1916-1918(3)
Authors: Almawi W.Y.; Melemedjian O.K.

Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease?
pp. 1919-1921(3)
Author: Zoccali C.

Interventional strategies for haemodialysis fistulae and grafts: interventional radiology or surgery?
pp. 1922-1923(2)
Author: Konner K.

Drug holiday: a challenging child–adult interface in kidney transplantation
pp. 1924-1927(4)
Authors: Cochat P.; De Geest S.; Ritz E.

₂-Adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin
pp. 1928-1934(7)
Authors: Nakamura A.; Johns E.J.; Imaizumi A.; Yanagawa Y.; Kohsaka T.

Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension
pp. 1935-1942(8)
Authors: Assmann K.J.M.; Wolf G.; Wenzel U.; Stahl R.A.K.

Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol₂
pp. 1943-1949(7)
Authors: Fan S.L.-S.; Schroeder N.J.; Calverley M.J.; Burrin J.M.; Makin H.L.J.; Cunningham J.

Evidence-based medicine in nephrology: identifying and critically appraising the literature
pp. 1950-1955(6)
Authors: MacLeod A.M.; Campbell M.K.; Daly C.; Wallace S.A.; Cody D.J.; Donaldson C.; Grant A.M.; Khan I.H.; Lawrence P.; Vale L.

Abnormal expression of glomerular basement membrane laminins in membranous glomerulonephritis
pp. 1956-1964(9)
Authors: Fischer E.; Mougenot B.; Callard P.; Ronco P.; Rossert J.

Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes
pp. 1965-1970(6)
Authors: Zychma M.J.; Zukowska-Szczechowska E.; Lacka B.I.; Grzeszczak W.

Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein , lipoprotein lipase and cholesteryl ester transfer protein
pp. 1971-1976(6)
Authors: Hadjadj S.; Gallois Y.; Simard G.; Bouhanick B.; Passa P.; Grimaldi A.; Drouin P.; Tichet J.; Marre M.

Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome
pp. 1977-1985(9)
Authors: Beales P.L.; Reid H.A.S.; Griffiths M.H.; Maher E.R.; Flinter F.A.; Woolf A.S.

Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure
pp. 1986-1992(7)
Authors: Fouque D.; Wang P.; Laville M.; Boissel J-P.

Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
pp. 1993-1999(7)
Authors: Broeders N.; Knoop C.; Antoine M.; Tielemans C.; Abramowicz D.

Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998
pp. 2000-2006(7)
Authors: Jungers P.; Choukroun G.; Robino C.; Massy Z.A.; Taupin P.; Labrunie M.; Man N-K.; Landais P.

Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialysis population
pp. 2007-2013(7)
Authors: Richardson D.; Bartlett C.; Will E.J.

The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin : results from a randomized controlled multicentre trial
pp. 2014-2019(6)
Authors: Weiss L.G.; Clyne N.; Fihlho J.D.; Frisenette-Fich C.; Kurkus J.; Svensson B.

Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane
pp. 2020-2028(9)
Authors: Bonnefont-Rousselot D.; Lehmann E.; Jaudon M-C.; Delattre J.; Perrone B.; Rechke J-P.

Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology
pp. 2029-2036(8)
Authors: Turmel-Rodrigues L.; Pengloan J.; Baudin S.; Testou D.; Abaza M.; Dahdah G.; Mouton A.; Blanchard D.

Chemical peritonitis associated with high dialysate acetaldehyde concentrations
pp. 2037-2040(4)
Authors: Tuncer M.; Sarkaya M.; Sezer T.; Özcan S.; Süleymanlar G.; Yakupoglu G.; Ersoy F.F.

Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy
pp. 2041-2045(5)
Authors: López-Hoyos M.; Rodrigo E.; Escallada R.; Fernández-Fresnedo G.; Ruiz J.C.; Piñera C.; Cotorruelo J.G.; Zubimendi J.A.; de Francisco A.L.M.; Arias M.

Severe hypercalcaemia with normal serum calcitriol in a diabetic patient with chronic renal failure, autoimmune hepatitis and disseminated tuberculosis
pp. 2046-2049(4)
Authors: Wu C-H.; Yen T-H.; Huang J-Y.; Lee K-F.; Huang C-C.

Acute renal failure and paraplegia in a patient with a pelvic-ring fracture
pp. 2050-2052(3)
Authors: Rachmani R.; Levi Z.; Zissin R.; Bernheim J.; Korzets Z.

Non-diabetic nodular glomerulosclerosis recurring in a renal graft
pp. 2053-2056(4)
Authors: Ots M.; Kulla A.; Luman M.; Metsküla K.; Leiba V.; Ritz E.

Pituitary involvement in Wegener's granulomatosis
pp. 2057-2058(2)
Authors: Tappouni R.; Burns A.

New-onset anaemia following kidney transplantation
pp. 2059-2061(3)
Authors: Meeus G.; Messiaen T.; Verhoef G.; Vanrenterghem Y.

Association of medullary sponge kidney disease and multiple endocrine neoplasia type IIA due to RET gene mutation: is there a causal relationship?
pp. 2062-2063(2)
Authors: Diouf B.; Fary Ka E.H.; Calender A.; Giraud S.; Diop T.M.

Dietary salt intake and blood pressure control in haemodialysis patients
pp. 2063-2063(1)
Authors: Maduell F.; Navarro V.

Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome
pp. 2064-2065(2)
Authors: Agarwal D.K.; Gulati S.; Mehta A.; Kumar A.; Sharma R.K.; Mehta B.; Gupta A.; Gupta R.K.

Pregnancy, tacrolimus, and renal transplantation: survival of a 358-g baby
pp. 2065-2066(2)
Authors: Satchell S.; Moppett J.; Quinn M.; Nicholls A.

Announcements
pp. 2067-2069(3)

Wegener's granulomatosis: clinical course in 108 patients with renal involvement
NDT 2000; 15: 611–618
pp. 2069-2069(1)
Authors: Aasarød K.; Iversen1 B.M.; Hammerstrøm J.; Bostad2 L.; Vatten3 L.; Jørstad S.